Report Highlights
BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2011 to 2016. An assessment of the global catheter market was performed while considering all of its important segments (i.e., cardiovascular, urological, neurovascular, intravenous, and specialty catheters).
No. of Pages: 191
: Single User License - US$4850 Corporate User License - US$8500
REASONS FOR DOING THE STUDY
Catheterization procedures have steadily increased as interventional and less-invasive procedures have become more popular. Catheters are vital to the completion of many procedures, and some procedures or interventions, particularly in cardiovascular surgery and neurosurgery, could not be done without the use of catheters. In conducting this study, BCC was interested in determining the areas of catheter applications poised for growth and the reasons for their growth. New products and their future impact on the market were also assessed.
SCOPE OF REPORT
BCC investigated the current catheter market and based projections of total, geographic, and type of product market revenues through 2016 based on current and historical usage, geographical and socio/economic market trends, and new applications and products.
The scope of this study encompasses the six major application segments of the catheter market. BCC Research analyzes each type of catheter segment, determines its current market status, examines its impact on future markets, and presents growth forecasts over the next five years. Catheter material analysis, regulatory issues, and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.
METHODOLOGY
Both primary and secondary research methodologies were used in this report. BCC Research developed an analysis of each segment of the catheter industry depending on applications, using a historical base year of 2010. Estimated values used are based on manufacturers’ net revenues.
INTENDED AUDIENCE
This study will be of interest to catheter and device manufacturers, catheter material manufacturers, and venture capitalists and financial institutions involved in the healthcare industry.
Table of Contents
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
SCOPE OF REPORT 1
METHODOLOGY 1
INTENDED AUDIENCE 2
INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED BCC REPORTS 2
BCC ONLINE SERVICES 3
DISCLAIMER 3
CHAPTER TWO: SUMMARY 4
SUMMARY TABLE: GLOBAL CATHETER MARKET, BY REGION,
THROUGH 2016 ($ MILLIONS) 5
SUMMARY FIGURE GLOBAL CATHETER MARKET, BY REGION,
2011 AND 2016 (%) 5
CHAPTER THREE: OVERVIEW OF GLOBAL CATHETER INDUSTRY 7
CATHETER DEVELOPMENT 7
CATHETER CONSTRUCTION 7
CATHETER APPLICATIONS 8
TYPES OF CATHETERS 9
CARDIOVASCULAR CATHETERS 9
Use of Cardiovascular Catheters 9
Diagnostic Procedures and Cardiac Catheterization 10
Therapeutic Procedures 10
TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10
TABLE 2 TYPES OF CARDIAC CATHETERS 11
Angiography Catheters 11
Angiographic Catheter Features 11
EP Catheters 12
Cardiac Ablation Catheters 12
PCI Catheters 12
PCI and Stent Placement 13
TABLE 3 PCI PROCEDURES 13
Rapid Exchange Balloon Catheters 14
Over–the-Wire PCI Catheters 14
Guiding Catheter 14
Possible Complications 14
UROLOGICAL CATHETERS 15
Development of the Foley Catheter 15
Type of Urinary Catheterization 16
Intermittent Catheterization 16
Possible Complication of Intermittent Catheters 16
Indwelling Catheterization 17
Possible Complications from Indwelling Catheters 17
Suprapubic Catheterization 17
Possible Complications from Suprapubic Catheterization 18
Male External Condom Catheterization 18
Possible Complications From Urinary Catheter Use 19
NEUROVASCULAR CATHETERS 19
INTRAVENOUS (IV) CATHETERS 20
Single-Lumen Catheters 20
Multi-Lumen Catheter 21
Specialty IV Catheters 21
Peripheral Vein Catheter 21
Central Venous Catheter (CVC) 21
Tunneling Insertion 22
Implantation Insertion 22
Advantages to Central Venous Catheters 22
Peripherally Inserted Central Catheters (PICCs) 23
Advantages of PICC Lines 23
Possible Complications due to IV Catheters 23
TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 23
SPECIALTY CATHETERS 24
Thermodilution Catheters 24
Suction Catheters 25
Oximetry Catheters 25
END-USER PREFERENCES 26
SIZE OF CATHETER 26
MATERIAL USED 26
COATING 27
LENGTH OF TIME CATHETER IS IN THE BODY 27
INFECTION RATE 27
COST 28
CHAPTER FOUR: CATHETERS AND WORLD DEMOGRAPHICS 29
CATHETER-ASSOCIATED INFECTIONS FROM SELECTED
PROCEDURES 29
TABLE 5 GLOBAL TRENDS IN CATHETER-ASSOCIATED
INFECTIONS BY ESTIMATED NUMBER OF INFECTIONS PER PROCEDURE TYPE, 2006-2009 (THOUSANDS) 29
CORONARY PROCEDURES 29
TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2007* (PER 100,000 POPULATIONS) 30
WORLDWIDE ECONOMIC DEMOGRAPHICS 30
TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 2003-2009* (%) 31
WORLDWIDE POPULATION GROWTH 32
CHAPTER FIVE: CATHETER MATERIALS 33
TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 33
KEY CHARACTERISTICS 33
SURFACE CHARACTERISTICS 34
CATHETER USE IN ADVANCED IMAGING 34
MRA 34
OCT 35
RADIOPACITY IN CATHETERS 35
Determining Appropriate Properties of Radiopaque
Catheters 36
Economics of Radiopacity 36
COMPONENT MATERIALS 37
LATEX 37
Latex Allergic Reactions 37
SILICONE 37
Silicone Catheter Characteristics 38
Disadvantage of Silicone Catheters 38
Cost Considerations for Silicone Catheters 38
POLYTETRAFLUOROETHYLENE (PTFE) 38
Uses 39
Cost Considerations 39
POLYURETHANE (PU) 39
Uses 39
Cost Considerations 40
POLYVINYL CHLORIDE (PVC) 40
Uses 40
Cost Considerations 40
POLYETHYLENE 40
Uses 40
Cost Considerations 40
CATHETER COATINGS 41
SILICONE ELASTOMER 41
HYDROPHILIC COATING 41
ANTIMICROBIAL COATING 41
Combating UTI 42
Combining Hydrophilic and Antimicrobial Coatings 42
Silver Coating 42
ADVANTAGES AND DISADVANTAGES OF CATHETER
MATERIALS 42
TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER
MATERIALS 43
CHAPTER SIX: ANALYSIS OF THE GLOBAL CATHETER MARKET 44
FACTORS INFLUENCING MARKET GROWTH 44
FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 44
DEMOGRAPHIC TRENDS 45
SURGICAL AND MEDICAL TRENDS 45
PCI Versus CABG 45
Combined Therapies 46
Expansion of Microcatheter Use 46
CATHETER REUSE 46
PRODUCT DISTRIBUTION 46
REIMBURSEMENT AND REGULATION TRENDS 46
Global Financial Conditions 47
Third-party Coverage and Reimbursement 47
Global Cost Containment 48
LEADING MANUFACTURERS 48
TABLE 10 TOTAL REVENUES OF KEY CATHETER MANUFACTURERS, 2009 AND 2010 ($ MILLIONS) 49
MERGERS/ACQUISITIONS IN THE CATHETER MARKET 49
TABLE 11 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET 2007-2011 50
KEY MARKET DRIVERS 50
INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 50
INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND TRANSMITTABLE DISEASE 51
NEW TECHNOLOGIES IN CATHETER DESIGN HAVE INCREASED CATHETER USE 51
INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS EXPANDED SALES 51
ADVANCES IN IMAGING TECHNOLOGY HAVE LED TO NEW APPLICATIONS REQUIRING THE USE OF CATHETERS 52
KEY MARKET RESTRAINTS 52
PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING 52
REVENUES 52
LONGER APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS 53
REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCED CATHETERS 53
EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICE TECHNOLOGIES 53
GLOBAL CATHETER REVENUE ANALYSIS 53
TABLE 12 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2016 ($ MILLIONS) 54
CARDIOVASCULAR CATHETERS 54
KEY MARKET CHALLENGES 55
Pharmacological Approaches Could Threaten Catheter Demand 55
Lack of Clinical Data Is Hindering Acceptance of Newer Catheters by Physicians and Healthcare Purchasing Organizations 55
KEY MARKET DRIVERS FOR THE CARDIOVASCULAR SEGMENT 55
Increases in the Incidence of Cardiovascular Diseases is Driving the Number of Procedures 55
Popularity of Angioplasty and Stent Placement over Bypass Surgery Is Leading to an Increase in the Use of Cardiac Catheters 56
Angiography Is Driving the Increase in the Number of Diagnostic Procedures 56
Interventional Cardiac Procedures Can Be More Effective than Pharmaceutical-based Therapies 57
KEY MARKET RESTRAINTS IN THE CARDIOVASCULAR MARKET 57
Constant Price Erosion Is Leading to Decreased Revenues 57
Decrease in Restenosis is Affecting the Number of Stent Procedures Performed 57
Catheter Usages Is Restrained due to Low Reimbursement Rates 58
CATHETER USE IN CONJUNCTION WITH STENT PLACEMENT 58
Exit of Cordis from Stent Market 59
CARDIOVASCULAR CATHETER REVENUE ANALYSIS 59
TABLE 13 PROJECTED GLOBAL MARKET FOR CARDIOVASCULAR
CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 60
Angiography 60
EP Mapping Catheters 60
Balloon Catheters 61
Rapid-exchange Catheters 61
Guiding Catheters 61
Intravascular Ultrasound Catheters (IVUS) 62
MARKET SHARES BY COMPANY 62
UROLOGICAL SEGMENT 62
Market Challenges 63
Market Drivers 63
Global Aging of the Population 63
Catheters with Antimicrobial Coatings Are
Increasing confidence in the Use of Catheters 63
Urological Catheter Market Revenues 64
Intermittent Catheter Revenues 64
Indwelling Catheter Revenues 64
TABLE 14 PROJECTED GLOBAL MARKET FOR UROLOGICAL
CATHETERS, BY TYPE, THROUGH 2016 ($ MILLIONS) 64
FIGURE 2 PROJECTED GLOBAL MARKET SHARE FOR
UROLOGICAL CATHETERS, BY COMPANY, 2010 (%) 65
INTRAVENOUS 65
TABLE 15 PROJECTED GLOBAL MARKET FOR INTRAVENOUS
CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 66
FIGURE 3 GLOBAL MARKET SHARE FOR IV CATHETERS, BY COMPANY, 2010 (%) 66
NEUROVASCULAR SEGMENT 67
Key Market Challenges 67
Cost of Neurovascular Catheters 67
Availability of Pharmacological Treatment Options 68
Shortage of Qualified Professionals to Perform Surgeries 68
Key Market Drivers 68
Enhanced Diagnostic and Imaging Technologies Are Creating New Areas of Treatment 68
Stenting and Aneurysm Treatments Are Increasing Microcatheter Use 68
New Catheter Technologies Are Improving Procedures and Increasing Demand 69
Expanding Market for Unmet Treatment Options 69
Neurovascular Catheter Market Revenues 69
TABLE 16 PROJECTED GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 70
Market Share by Company 70
FIGURE 4 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2011 (%) 71
SPECIALTY CATHETER MARKET 71
Types of Specialty Catheters 71
Key Market Drivers 72
Demand for Enhanced Monitoring Devices Is Contributing to Expanded Sales 72
Effectiveness of Specialty Catheters Is Fueling Growth in Use 72
Key Market Restraints 72
Increased Cost of Specialty Catheters Inhibit Sales 72
Introduction of Competing Technologies 72
Use of Thrombolytic Drugs 73
Specialty Catheter Market Revenue Analysis 73
TABLE 17 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2016 ($ MILLIONS) 73
Specialty Catheter Market Analysis 73
Specialty Catheter Market Shares by Company and Catheter Type 74
TABLE 18 GLOBAL SPECIALTY CATHETER MARKET SHARES, BY COMPANY AND TYPE OF CATHETER, 2010 (%) 74
GLOBAL MARKET SHARE FORECAST BY TYPE OF CATHETER 75
FIGURE 5 PERCENT OF MARKET SHARE BY TYPE OF CATHETER 2011 AND 2016 (%) 75
CONSEQUENCES OF THE ONGOING GLOBAL ECONOMIC RECESSION 76
PROJECTIONS FOR GLOBAL CATHETER MARKET BY REGION 76
TABLE 19 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2016 ($ MILLIONS) 77
MARKET REVENUE, BY REGION 77
Reusable Catheter Use in World Market 77
GEOGRAPHIC MARKET SHARE BY 2016 78
EMERGING TECHNOLOGIES 78
BIOABSORBABLE STENTS 78
BIFURCATED STENTS 79
UROVALVE INC 79
VOLCANO CORPORATION 80
CHAPTER SEVEN: THE AMERICAS CATHETER MARKET 81
GDP AND PERCENT SPENT ON HEALTHCARE IN THE AMERICAS 81
TABLE 20 GDP AND EXPENDITURE ON HEALTHCARE AS A SHARE OF GDP IN THE AMERICAS, 2009 81
CATHETER MARKET IN THE AMERICAS 81
TABLE 21 PROJECTED AMERICAS MARKET FOR CATHETERS BY COUNTRY, THROUGH 2016 ($ MILLIONS) 82
REVENUE ANALYSIS FOR THE AMERICAS’ CATHETER MARKET, BY TYPE OF CATHETER 82
TABLE 22 PROJECTED AMERICAS MARKET FOR CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 82
THE CANADIAN MARKET 83
THE MEXICAN MARKET 83
THE LATIN AMERICAN MARKET 83
THE SOUTH AMERICAN MARKET 83
THE US MARKET 83
US ECONOMIC CONDITIONS 84
EFFECTS OF HEALTHCARE REFORM IN THE US 84
REIMBURSEMENT 84
Denial of Reimbursement in US 85
US REGULATIONS 85
US Regulations and Reprocessing 85
CARDIOVASCULAR DISEASE 86
TABLE 23 US RATES OF CARDIOVASCULAR PROCEDURES, 2007- 2009 (THOUSANDS) 86
TRENDS IN PROCEDURE USAGE 86
COSTS OF HEART DISEASE IN THE US 87
REVENUE ANALYSIS FOR CARDIOVASCULAR CATHETERS IN THE AMERICAS 87
TABLE 24 PROJECTED AMERICAS MARKET FOR CARDIOVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 87
AMERICAS MARKET TRENDS IN CARDIOVASCULAR CATHETERS 88
URINARY CATHETERS 88
TABLE 25 PROJECTED AMERICAS MARKET FOR URINARY CATHETERS, THROUGH 2016 ($ MILLIONS) 88
AMERICAS MARKET TRENDS IN URINARY CATHETERS 88
INTRAVENOUS CATHETERS 89
TABLE 26 PROJECTED AMERICAS MARKET FOR INTRAVENOUS CATHETERS, THROUGH 2016 ($ MILLIONS) 90
AMERICAS MARKET TRENDS FOR INTRAVENOUS CATHETERS 90
NEUROVASCULAR 90
TABLE 27 PROJECTED AMERICAS MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 91
AMERICAS MARKET TRENDS FOR NEUROVASCULAR CATHETERS 91
SPECIALTY 91
TABLE 28 PROJECTED AMERICAS MARKET FOR SPECIALTY CATHETERS, THROUGH 2016 ($ MILLIONS) 92
AMERICAS MARKET TRENDS FOR SPECIALTY CATHETERS 92
CHAPTER EIGHT: THE EUROPEAN, MIDDLE EAST, RUSSIAN, AND AFRICAN CATHETER MARKET 93
WESTERN EUROPEAN HEALTHCARE SYSTEMS 93
EASTERN EUROPEAN AND AFRICAN HEALTHCARE SYSTEMS 93
MIDDLE EASTERN HEALTHCARE SYSTEMS 94
MEDICAL TOURISM IN THE MIDDLE EAST 94
RUSSIAN HEALTHCARE SYSTEMS 94
HEALTHCARE IN RUSSIA 95
TABLE 29 TOTAL EXPENDITURE ON HEALTHCARE AS A SHARE OF GDP IN SELECTED EMRA COUNTRIES, 2009 ($ MILLIONS/%) 96
TABLE 30 PROJECTED EMRA MARKET FOR CATHETERS BY REGION, THROUGH 2016 ($ MILLIONS) 97
TABLE 31 PROJECTED EMRA MARKET FOR CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 98
GOVERNMENT REGULATIONS 98
MARKET GROWTH IN EMRA COUNTRIES 98
ECONOMIC CONDITIONS 99
CARDIOVASCULAR MARKET 99
TABLE 32 PROJECTED EMRA MARKET FOR CARDIOVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 100
TRENDS IN THE EMRA CARDIOVASCULAR CATHETER MARKET 100
UROLOGY CATHETER MARKET 100
TABLE 33 PROJECTED EMRA MARKET FOR UROLOGICAL CATHETERS, THROUGH 2016 ($ MILLIONS) 101
TRENDS IN THE EMRA UROLOGICAL CATHETER MARKET 101
INTRAVENOUS CATHETER MARKET 101
TABLE 34 PROJECTED EMRA MARKET FOR INTRAVENOUS CATHETERS, THROUGH 2016 ($ MILLIONS) 101
TRENDS IN THE EMRA INTRAVENOUS CATHETER MARKET 102
NEUROVASCULAR CATHETER MARKET 102
TABLE 35 PROJECTED EMRA MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 102
TRENDS IN THE EMRA NEUROVASCULAR CATHETER MARKET 102
SPECIALTY CATHETER MARKET 103
TABLE 36 PROJECTED EMRA MARKET FOR SPECIALTY CATHETERS, THROUGH 2016 ($ MILLIONS) 103
TRENDS IN THE EMRA SPECIALTY CATHETER MARKET 103
CHAPTER NINE: THE ASIAN CATHETER MARKET 104
REGIONAL ECONOMIC CONSIDERATIONS 104
TABLE 37 PROJECTED ASIAN CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 104
GDP AND GROWTH RATES 105
TABLE 38 GDP OF SELECTED ASIAN COUNTRIES, GDP GROWTH RATE, PERCENT OF GDP DEVOTED TO HEALTHCARE 105
REGULATIONS AND HEALTHCARE COVERAGE IN THE
AUSTRALIAN MARKET 105
Health Insurance in Australia 106
REGULATIONS AND HEALTHCARE COVERAGE IN THE
JAPANESE MARKET 106
REGULATIONS AND HEALTHCARE COVERAGE IN THE
INDIAN MARKET 106
Medical Insurance in India 107
Growth of the Indian Healthcare Industry 107
REGULATIONS AND HEALTHCARE COVERAGE IN THE CHINESE MARKET 107
Medical Device Regulations 107
Chinese Healthcare Institutions 108
Rural and Urban Healthcare Services 108
ASIAN CATHETER MARKET BY TYPE OF PRODUCT 109
TABLE 39 PROJECTED ASIAN CATHETER MARKET BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 109
CARDIOVASCULAR MARKET 109
TABLE 40 PROJECTED ASIAN CARDIOVASCULAR CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 110
Trends in the Asian Cardiovascular Catheter Market 110
UROLOGY CATHETER MARKET 110
TABLE 41 PROJECTED ASIAN UROLOGY CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 111
Trends in the Asian Urological Catheter Market 111
INTRAVENOUS CATHETER MARKET 111
TABLE 42 PROJECTED ASIAN INTRAVENOUS CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 111
Trends in the Asian IV Catheter Market 112
NEUROVASCULAR CATHETER MARKET 112
TABLE 43 PROJECTED ASIAN NEUROVASCULAR CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 112
Trends in the Asian Neurological Catheter Market 112
SPECIALTY CATHETER MARKET 113
TABLE 44 PROJECTED ASIAN SPECIALTY CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 113
Trends in the Asian Specialty Catheter Market 113
CHAPTER TEN: PATENT ANALYSIS 114
GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 114
TABLE 45 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 114
CATHETER PATENT ACTIVITY BY ASSIGNEE 115
TABLE 46 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY 2008-SEPTEMBER 2011 (NUMBER OF
PATENTS) 115
CARDIOVASCULAR CATHETER PATENTS 116
TABLE 47 CARDIOVASCULAR CATHETER PATENTS BY TYPE, JANUARY 2008-SEPTEMBER 2011 116
TABLE 48 CARDIAC CATHETER PATENTS, NOVEMBER 2011- JANUARY 2008 117
TABLE 49 BALLOON CATHETER PATENTS, APRIL 2011-JANUARY 2008 120
TABLE 50 CARDIAC GUIDE CATHETER PATENTS, NOVEMBER 2011-JANUARY 2008 121
TABLE 51 CARDIAC GUIDEWIRE PATENTS, 2010 122
UROLOGY CATHETER PATENTS 122
IV CATHETER PATENTS 122
TABLE 52 IV CATHETER PATENTS BY TYPE, JANUARY 2008- SEPTEMBER 2011 122
TABLE 53 IV CATHETER PATENTS, JUNE 2009-SEPTEMBER 2008 123
SPECIALTY CATHETER PATENTS 123
TABLE 54 SPECIALTY CATHETER PATENTS BY TYPE, JANUARY 2008-SEPTEMBER 2011 124
TABLE 55 SPECIALTY CATHETER PATENTS, OCTOBER 2011 124
CATHETER COATINGS 126
TABLE 56 CATHETER COATING PATENTS, JANUARY 2008-SEPTEMBER 2011 126
TABLE 57 CATHETER COATING PATENTS, JULY 2011-JUNE 2009 126
CHAPTER ELEVEN: COMPANY DIRECTORY 128
ABBOTT LABORATORIES 128
BUSINESS OVERVIEW 128
FINANCIAL 128
PRODUCTS 129
TABLE 58 ABBOTT LABORATORIES CATHETER PRODUCTS 129
ANGIODYNAMICS 129
BUSINESS OVERVIEW 129
FINANCIALS 130
PRODUCTS 130
TABLE 59 ANGIODYNAMICS CATHETER PRODUCTS 130
ASTRA TECH INC, UROLOGY DIVISION 130
BUSINESS OVERVIEW 131
FINANCIALS 131
PRODUCTS 131
TABLE 60 ASTRA TECH CATHETER PRODUCTS 131
B BRAUN MELSUNGEN AG 132
BUSINESS OVERVIEW 132
FINANCIALS 132
PRODUCTS 132
TABLE 61 B BRAUN CATHETER PRODUCTS 132
BECTON DICKINSON & CO 133
BUSINESS OVERVIEW 133
FINANCIALS 134
PRODUCTS 134
TABLE 62 BD CATHETER PRODUCTS 134
BOSTON SCIENTIFIC 134
BUSINESS OVERVIEW 135
FINANCIALS 135
PRODUCTS 135
TABLE 63 BOSTON SCIENTIFIC CATHETER PRODUCTS 135
CARDINAL HEALTH 136
BUSINESS OVERVIEW 136
FINANCIALS 137
PRODUCTS 137
TABLE 64 CARDINAL HEALTH CATHETER PRODUCTS 137
CAREFUSION CORP 137
BUSINESS OVERVIEW 138
FINANCIALS 138
PRODUCTS 138
TABLE 65 CAREFUSION CATHETER PRODUCTS 138
CODMAN & SHURTLEFF (DEPUY) 138
BUSINESS OVERVIEW 138
FINANCIALS 139
PRODUCTS 139
TABLE 66 CODMAN & SHURTLEFF CATHETER PRODUCTS 139
COLOPLAST GROUP 139
FINANCIALS 140
PRODUCTS 140
TABLE 67 COLOPLAST CATHETER PRODUCTS 140
COOK MEDICAL 140
BUSINESS OVERVIEW 140
FINANCIALS 141
PRODUCTS 141
TABLE 68 COOK MEDICAL CATHETER PRODUCTS 141
COVIDIEN 142
BUSINESS OVERVIEW 142
FINANCIALS 142
PRODUCTS 143
TABLE 69 COVIDIEN CATHETER PRODUCTS 143
C R BARD 144
BUSINESS OVERVIEW 144
FINANCIALS 144
PRODUCTS 144
TABLE 70 C R BARD CATHETER PRODUCTS 144
EDWARDS LIFESCIENCES 146
BUSINESS OVERVIEW 146
FINANCIALS 146
PRODUCTS 147
TABLE 71 EDWARDS LIFESCIENCES CATHETER PRODUCTS 147
EV3 ENDOVASCULAR INC (COVIDIEN) 147
BUSINESS OVERVIEW 147
FINANCIALS 147
PRODUCTS 148
TABLE 72 EV3 CATHETER PRODUCTS 148
GOODMAN CO LTD 148
BUSINESS OVERVIEW 148
FINANCIALS 149
PRODUCTS 149
TABLE 73 GOODMAN CATHETER PRODUCTS 149
HOLLISTER 149
BUSINESS OVERVIEW 149
FINANCIALS 149
PRODUCTS 150
TABLE 74 HOLLISTER CATHETER PRODUCTS 150
HOSPIRA INC 150
BUSINESS OVERVIEW 150
FINANCIALS 150
PRODUCTS 150
TABLE 75 HOSPIRA CATHETER PRODUCTS 150
ICU MEDICAL 151
BUSINESS OVERVIEW 151
FINANCIALS 151
PRODUCTS 151
TABLE 76 ICU MEDICAL CATHETER PRODUCTS 151
INTEGRA LIFE SCIENCES 152
BUSINESS OVERVIEW 152
FINANCIALS 152
PRODUCTS 152
TABLE 77 INTEGRA LIFESCIENCES CATHETER PRODUCTS 152
JOHNSON & JOHNSON 152
BUSINESS OVERVIEW 153
FINANCIALS 153
PRODUCTS 153
TABLE 78 JOHNSON & JOHNSON CATHETER PRODUCTS 153
KIMBERLY CLARK HEALTHCARE 154
BUSINESS OVERVIEW 154
FINANCIALS 155
PRODUCTS 155
TABLE 79 KIMBERLY CLARK HEALTHCARE CATHETER PRODUCTS 155
MEDCOMP 155
BUSINESS OVERVIEW 155
FINANCIALS 155
PRODUCTS 156
TABLE 80 MEDCOMP CATHETER PRODUCTS 156
MEDLINE INDUSTRIES 156
BUSINESS OVERVIEW 156
FINANCIALS 157
PRODUCTS 157
TABLE 81 MEDLINE CATHETER PRODUCTS 157
MEDRAD (BAYER AG) 157
BUSINESS OVERVIEW 157
FINANCIALS 158
PRODUCTS 158
TABLE 82 MEDRAD CATHETER PRODUCTS 158
MEDTRONIC 158
BUSINESS OVERVIEW 158
FINANCIALS 159
PRODUCTS 159
TABLE 83 MEDTRONIC CATHETER PRODUCTS 159
MERIT MEDICAL SYSTEMS 160
BUSINESS OVERVIEW 160
FINANCIALS 160
PRODUCTS 160
TABLE 84 MERIT MEDICAL CATHETER PRODUCTS 160
NAVILYST MEDICAL 161
BUSINESS OVERVIEW 161
FINANCIALS 161
PRODUCTS 162
TABLE 85 NAVILYST MEDICAL CATHETER PRODUCTS 162
PULSION MEDICAL AG 162
BUSINESS OVERVIEW 162
FINANCIALS 162
PRODUCTS 163
TABLE 86 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS 163
ROCHESTER MEDICAL 163
BUSINESS OVERVIEW 163
FINANCIALS 163
PRODUCTS 164
TABLE 87 ROCHESTER MEDICAL CATHETER PRODUCTS 164
SMITHS MEDICAL 164
BUSINESS OVERVIEW 164
FINANCIALS 165
PRODUCTS 165
TABLE 88 SMITHS MEDICAL CATHETER PRODUCTS 165
ST JUDE MEDICAL 166
BUSINESS OVERVIEW 166
FINANCIALS 166
PRODUCTS 166
TABLE 89 ST JUDE MEDICAL CATHETER PRODUCTS 166
STRYKER 167
BUSINESS OVERVIEW 167
FINANCIALS 168
PRODUCTS 168
TABLE 90 STRYKER CATHETER PRODUCTS 168
TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 168
BUSINESS OVERVIEW 168
FINANCIALS 169
PRODUCTS 169
TABLE 91 TELEFLEX CATHETER PRODUCTS 169
TERUMO MEDICAL CORP 170
BUSINESS OVERVIEW 170
FINANCIALS 170
PRODUCTS 170
TABLE 92 TERUMO CATHETER PRODUCTS 170
VASCULAR SOLUTIONS 171
BUSINESS OVERVIEW 171
FINANCIALS 172
PRODUCTS 172
TABLE 93 VASCULAR SOLUTIONS CATHETER PRODUCTS 172
VOLCANO CORPORATION 172
BUSINESS OVERVIEW 172
FINANCIALS 173
PRODUCTS 173
TABLE 94 VOLCANO CORPORATION CATHETER PRODUCTS 173
APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 174
TABLE 95 CATHETER PRODUCTS BY APPLICATION, TYPE, BRAND NAME, AND MANUFACTURER 174
- The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
- In 2011, the American region of the market accounted for $11.5 billion and is projected to reach $12.0 billion by the end of forecast period in 2016. The CAGR for the Americas is projected to be 0.7% during the period 2011 to 2016.
- Catheter sales in the region comprised of Western Europe, Eastern Europe, the Middle East, Russia, and Africa (EMRA), were an estimated $6.6 billion in 2011 and are estimated to grow at a CAGR of 15.6% reaching $13.7 billion by 2016.
BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2011 to 2016. An assessment of the global catheter market was performed while considering all of its important segments (i.e., cardiovascular, urological, neurovascular, intravenous, and specialty catheters).
Catheters Industry Report
Published: January 2012No. of Pages: 191
: Single User License - US$4850 Corporate User License - US$8500
REASONS FOR DOING THE STUDY
Catheterization procedures have steadily increased as interventional and less-invasive procedures have become more popular. Catheters are vital to the completion of many procedures, and some procedures or interventions, particularly in cardiovascular surgery and neurosurgery, could not be done without the use of catheters. In conducting this study, BCC was interested in determining the areas of catheter applications poised for growth and the reasons for their growth. New products and their future impact on the market were also assessed.
SCOPE OF REPORT
BCC investigated the current catheter market and based projections of total, geographic, and type of product market revenues through 2016 based on current and historical usage, geographical and socio/economic market trends, and new applications and products.
The scope of this study encompasses the six major application segments of the catheter market. BCC Research analyzes each type of catheter segment, determines its current market status, examines its impact on future markets, and presents growth forecasts over the next five years. Catheter material analysis, regulatory issues, and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.
METHODOLOGY
Both primary and secondary research methodologies were used in this report. BCC Research developed an analysis of each segment of the catheter industry depending on applications, using a historical base year of 2010. Estimated values used are based on manufacturers’ net revenues.
INTENDED AUDIENCE
This study will be of interest to catheter and device manufacturers, catheter material manufacturers, and venture capitalists and financial institutions involved in the healthcare industry.
Table of Contents
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
SCOPE OF REPORT 1
METHODOLOGY 1
INTENDED AUDIENCE 2
INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED BCC REPORTS 2
BCC ONLINE SERVICES 3
DISCLAIMER 3
CHAPTER TWO: SUMMARY 4
SUMMARY TABLE: GLOBAL CATHETER MARKET, BY REGION,
THROUGH 2016 ($ MILLIONS) 5
SUMMARY FIGURE GLOBAL CATHETER MARKET, BY REGION,
2011 AND 2016 (%) 5
CHAPTER THREE: OVERVIEW OF GLOBAL CATHETER INDUSTRY 7
CATHETER DEVELOPMENT 7
CATHETER CONSTRUCTION 7
CATHETER APPLICATIONS 8
TYPES OF CATHETERS 9
CARDIOVASCULAR CATHETERS 9
Use of Cardiovascular Catheters 9
Diagnostic Procedures and Cardiac Catheterization 10
Therapeutic Procedures 10
TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10
TABLE 2 TYPES OF CARDIAC CATHETERS 11
Angiography Catheters 11
Angiographic Catheter Features 11
EP Catheters 12
Cardiac Ablation Catheters 12
PCI Catheters 12
PCI and Stent Placement 13
TABLE 3 PCI PROCEDURES 13
Rapid Exchange Balloon Catheters 14
Over–the-Wire PCI Catheters 14
Guiding Catheter 14
Possible Complications 14
UROLOGICAL CATHETERS 15
Development of the Foley Catheter 15
Type of Urinary Catheterization 16
Intermittent Catheterization 16
Possible Complication of Intermittent Catheters 16
Indwelling Catheterization 17
Possible Complications from Indwelling Catheters 17
Suprapubic Catheterization 17
Possible Complications from Suprapubic Catheterization 18
Male External Condom Catheterization 18
Possible Complications From Urinary Catheter Use 19
NEUROVASCULAR CATHETERS 19
INTRAVENOUS (IV) CATHETERS 20
Single-Lumen Catheters 20
Multi-Lumen Catheter 21
Specialty IV Catheters 21
Peripheral Vein Catheter 21
Central Venous Catheter (CVC) 21
Tunneling Insertion 22
Implantation Insertion 22
Advantages to Central Venous Catheters 22
Peripherally Inserted Central Catheters (PICCs) 23
Advantages of PICC Lines 23
Possible Complications due to IV Catheters 23
TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 23
SPECIALTY CATHETERS 24
Thermodilution Catheters 24
Suction Catheters 25
Oximetry Catheters 25
END-USER PREFERENCES 26
SIZE OF CATHETER 26
MATERIAL USED 26
COATING 27
LENGTH OF TIME CATHETER IS IN THE BODY 27
INFECTION RATE 27
COST 28
CHAPTER FOUR: CATHETERS AND WORLD DEMOGRAPHICS 29
CATHETER-ASSOCIATED INFECTIONS FROM SELECTED
PROCEDURES 29
TABLE 5 GLOBAL TRENDS IN CATHETER-ASSOCIATED
INFECTIONS BY ESTIMATED NUMBER OF INFECTIONS PER PROCEDURE TYPE, 2006-2009 (THOUSANDS) 29
CORONARY PROCEDURES 29
TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2007* (PER 100,000 POPULATIONS) 30
WORLDWIDE ECONOMIC DEMOGRAPHICS 30
TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 2003-2009* (%) 31
WORLDWIDE POPULATION GROWTH 32
CHAPTER FIVE: CATHETER MATERIALS 33
TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 33
KEY CHARACTERISTICS 33
SURFACE CHARACTERISTICS 34
CATHETER USE IN ADVANCED IMAGING 34
MRA 34
OCT 35
RADIOPACITY IN CATHETERS 35
Determining Appropriate Properties of Radiopaque
Catheters 36
Economics of Radiopacity 36
COMPONENT MATERIALS 37
LATEX 37
Latex Allergic Reactions 37
SILICONE 37
Silicone Catheter Characteristics 38
Disadvantage of Silicone Catheters 38
Cost Considerations for Silicone Catheters 38
POLYTETRAFLUOROETHYLENE (PTFE) 38
Uses 39
Cost Considerations 39
POLYURETHANE (PU) 39
Uses 39
Cost Considerations 40
POLYVINYL CHLORIDE (PVC) 40
Uses 40
Cost Considerations 40
POLYETHYLENE 40
Uses 40
Cost Considerations 40
CATHETER COATINGS 41
SILICONE ELASTOMER 41
HYDROPHILIC COATING 41
ANTIMICROBIAL COATING 41
Combating UTI 42
Combining Hydrophilic and Antimicrobial Coatings 42
Silver Coating 42
ADVANTAGES AND DISADVANTAGES OF CATHETER
MATERIALS 42
TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER
MATERIALS 43
CHAPTER SIX: ANALYSIS OF THE GLOBAL CATHETER MARKET 44
FACTORS INFLUENCING MARKET GROWTH 44
FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 44
DEMOGRAPHIC TRENDS 45
SURGICAL AND MEDICAL TRENDS 45
PCI Versus CABG 45
Combined Therapies 46
Expansion of Microcatheter Use 46
CATHETER REUSE 46
PRODUCT DISTRIBUTION 46
REIMBURSEMENT AND REGULATION TRENDS 46
Global Financial Conditions 47
Third-party Coverage and Reimbursement 47
Global Cost Containment 48
LEADING MANUFACTURERS 48
TABLE 10 TOTAL REVENUES OF KEY CATHETER MANUFACTURERS, 2009 AND 2010 ($ MILLIONS) 49
MERGERS/ACQUISITIONS IN THE CATHETER MARKET 49
TABLE 11 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET 2007-2011 50
KEY MARKET DRIVERS 50
INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 50
INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND TRANSMITTABLE DISEASE 51
NEW TECHNOLOGIES IN CATHETER DESIGN HAVE INCREASED CATHETER USE 51
INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS EXPANDED SALES 51
ADVANCES IN IMAGING TECHNOLOGY HAVE LED TO NEW APPLICATIONS REQUIRING THE USE OF CATHETERS 52
KEY MARKET RESTRAINTS 52
PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING 52
REVENUES 52
LONGER APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS 53
REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCED CATHETERS 53
EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICE TECHNOLOGIES 53
GLOBAL CATHETER REVENUE ANALYSIS 53
TABLE 12 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2016 ($ MILLIONS) 54
CARDIOVASCULAR CATHETERS 54
KEY MARKET CHALLENGES 55
Pharmacological Approaches Could Threaten Catheter Demand 55
Lack of Clinical Data Is Hindering Acceptance of Newer Catheters by Physicians and Healthcare Purchasing Organizations 55
KEY MARKET DRIVERS FOR THE CARDIOVASCULAR SEGMENT 55
Increases in the Incidence of Cardiovascular Diseases is Driving the Number of Procedures 55
Popularity of Angioplasty and Stent Placement over Bypass Surgery Is Leading to an Increase in the Use of Cardiac Catheters 56
Angiography Is Driving the Increase in the Number of Diagnostic Procedures 56
Interventional Cardiac Procedures Can Be More Effective than Pharmaceutical-based Therapies 57
KEY MARKET RESTRAINTS IN THE CARDIOVASCULAR MARKET 57
Constant Price Erosion Is Leading to Decreased Revenues 57
Decrease in Restenosis is Affecting the Number of Stent Procedures Performed 57
Catheter Usages Is Restrained due to Low Reimbursement Rates 58
CATHETER USE IN CONJUNCTION WITH STENT PLACEMENT 58
Exit of Cordis from Stent Market 59
CARDIOVASCULAR CATHETER REVENUE ANALYSIS 59
TABLE 13 PROJECTED GLOBAL MARKET FOR CARDIOVASCULAR
CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 60
Angiography 60
EP Mapping Catheters 60
Balloon Catheters 61
Rapid-exchange Catheters 61
Guiding Catheters 61
Intravascular Ultrasound Catheters (IVUS) 62
MARKET SHARES BY COMPANY 62
UROLOGICAL SEGMENT 62
Market Challenges 63
Market Drivers 63
Global Aging of the Population 63
Catheters with Antimicrobial Coatings Are
Increasing confidence in the Use of Catheters 63
Urological Catheter Market Revenues 64
Intermittent Catheter Revenues 64
Indwelling Catheter Revenues 64
TABLE 14 PROJECTED GLOBAL MARKET FOR UROLOGICAL
CATHETERS, BY TYPE, THROUGH 2016 ($ MILLIONS) 64
FIGURE 2 PROJECTED GLOBAL MARKET SHARE FOR
UROLOGICAL CATHETERS, BY COMPANY, 2010 (%) 65
INTRAVENOUS 65
TABLE 15 PROJECTED GLOBAL MARKET FOR INTRAVENOUS
CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 66
FIGURE 3 GLOBAL MARKET SHARE FOR IV CATHETERS, BY COMPANY, 2010 (%) 66
NEUROVASCULAR SEGMENT 67
Key Market Challenges 67
Cost of Neurovascular Catheters 67
Availability of Pharmacological Treatment Options 68
Shortage of Qualified Professionals to Perform Surgeries 68
Key Market Drivers 68
Enhanced Diagnostic and Imaging Technologies Are Creating New Areas of Treatment 68
Stenting and Aneurysm Treatments Are Increasing Microcatheter Use 68
New Catheter Technologies Are Improving Procedures and Increasing Demand 69
Expanding Market for Unmet Treatment Options 69
Neurovascular Catheter Market Revenues 69
TABLE 16 PROJECTED GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 70
Market Share by Company 70
FIGURE 4 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2011 (%) 71
SPECIALTY CATHETER MARKET 71
Types of Specialty Catheters 71
Key Market Drivers 72
Demand for Enhanced Monitoring Devices Is Contributing to Expanded Sales 72
Effectiveness of Specialty Catheters Is Fueling Growth in Use 72
Key Market Restraints 72
Increased Cost of Specialty Catheters Inhibit Sales 72
Introduction of Competing Technologies 72
Use of Thrombolytic Drugs 73
Specialty Catheter Market Revenue Analysis 73
TABLE 17 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2016 ($ MILLIONS) 73
Specialty Catheter Market Analysis 73
Specialty Catheter Market Shares by Company and Catheter Type 74
TABLE 18 GLOBAL SPECIALTY CATHETER MARKET SHARES, BY COMPANY AND TYPE OF CATHETER, 2010 (%) 74
GLOBAL MARKET SHARE FORECAST BY TYPE OF CATHETER 75
FIGURE 5 PERCENT OF MARKET SHARE BY TYPE OF CATHETER 2011 AND 2016 (%) 75
CONSEQUENCES OF THE ONGOING GLOBAL ECONOMIC RECESSION 76
PROJECTIONS FOR GLOBAL CATHETER MARKET BY REGION 76
TABLE 19 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2016 ($ MILLIONS) 77
MARKET REVENUE, BY REGION 77
Reusable Catheter Use in World Market 77
GEOGRAPHIC MARKET SHARE BY 2016 78
EMERGING TECHNOLOGIES 78
BIOABSORBABLE STENTS 78
BIFURCATED STENTS 79
UROVALVE INC 79
VOLCANO CORPORATION 80
CHAPTER SEVEN: THE AMERICAS CATHETER MARKET 81
GDP AND PERCENT SPENT ON HEALTHCARE IN THE AMERICAS 81
TABLE 20 GDP AND EXPENDITURE ON HEALTHCARE AS A SHARE OF GDP IN THE AMERICAS, 2009 81
CATHETER MARKET IN THE AMERICAS 81
TABLE 21 PROJECTED AMERICAS MARKET FOR CATHETERS BY COUNTRY, THROUGH 2016 ($ MILLIONS) 82
REVENUE ANALYSIS FOR THE AMERICAS’ CATHETER MARKET, BY TYPE OF CATHETER 82
TABLE 22 PROJECTED AMERICAS MARKET FOR CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 82
THE CANADIAN MARKET 83
THE MEXICAN MARKET 83
THE LATIN AMERICAN MARKET 83
THE SOUTH AMERICAN MARKET 83
THE US MARKET 83
US ECONOMIC CONDITIONS 84
EFFECTS OF HEALTHCARE REFORM IN THE US 84
REIMBURSEMENT 84
Denial of Reimbursement in US 85
US REGULATIONS 85
US Regulations and Reprocessing 85
CARDIOVASCULAR DISEASE 86
TABLE 23 US RATES OF CARDIOVASCULAR PROCEDURES, 2007- 2009 (THOUSANDS) 86
TRENDS IN PROCEDURE USAGE 86
COSTS OF HEART DISEASE IN THE US 87
REVENUE ANALYSIS FOR CARDIOVASCULAR CATHETERS IN THE AMERICAS 87
TABLE 24 PROJECTED AMERICAS MARKET FOR CARDIOVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 87
AMERICAS MARKET TRENDS IN CARDIOVASCULAR CATHETERS 88
URINARY CATHETERS 88
TABLE 25 PROJECTED AMERICAS MARKET FOR URINARY CATHETERS, THROUGH 2016 ($ MILLIONS) 88
AMERICAS MARKET TRENDS IN URINARY CATHETERS 88
INTRAVENOUS CATHETERS 89
TABLE 26 PROJECTED AMERICAS MARKET FOR INTRAVENOUS CATHETERS, THROUGH 2016 ($ MILLIONS) 90
AMERICAS MARKET TRENDS FOR INTRAVENOUS CATHETERS 90
NEUROVASCULAR 90
TABLE 27 PROJECTED AMERICAS MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 91
AMERICAS MARKET TRENDS FOR NEUROVASCULAR CATHETERS 91
SPECIALTY 91
TABLE 28 PROJECTED AMERICAS MARKET FOR SPECIALTY CATHETERS, THROUGH 2016 ($ MILLIONS) 92
AMERICAS MARKET TRENDS FOR SPECIALTY CATHETERS 92
CHAPTER EIGHT: THE EUROPEAN, MIDDLE EAST, RUSSIAN, AND AFRICAN CATHETER MARKET 93
WESTERN EUROPEAN HEALTHCARE SYSTEMS 93
EASTERN EUROPEAN AND AFRICAN HEALTHCARE SYSTEMS 93
MIDDLE EASTERN HEALTHCARE SYSTEMS 94
MEDICAL TOURISM IN THE MIDDLE EAST 94
RUSSIAN HEALTHCARE SYSTEMS 94
HEALTHCARE IN RUSSIA 95
TABLE 29 TOTAL EXPENDITURE ON HEALTHCARE AS A SHARE OF GDP IN SELECTED EMRA COUNTRIES, 2009 ($ MILLIONS/%) 96
TABLE 30 PROJECTED EMRA MARKET FOR CATHETERS BY REGION, THROUGH 2016 ($ MILLIONS) 97
TABLE 31 PROJECTED EMRA MARKET FOR CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS) 98
GOVERNMENT REGULATIONS 98
MARKET GROWTH IN EMRA COUNTRIES 98
ECONOMIC CONDITIONS 99
CARDIOVASCULAR MARKET 99
TABLE 32 PROJECTED EMRA MARKET FOR CARDIOVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 100
TRENDS IN THE EMRA CARDIOVASCULAR CATHETER MARKET 100
UROLOGY CATHETER MARKET 100
TABLE 33 PROJECTED EMRA MARKET FOR UROLOGICAL CATHETERS, THROUGH 2016 ($ MILLIONS) 101
TRENDS IN THE EMRA UROLOGICAL CATHETER MARKET 101
INTRAVENOUS CATHETER MARKET 101
TABLE 34 PROJECTED EMRA MARKET FOR INTRAVENOUS CATHETERS, THROUGH 2016 ($ MILLIONS) 101
TRENDS IN THE EMRA INTRAVENOUS CATHETER MARKET 102
NEUROVASCULAR CATHETER MARKET 102
TABLE 35 PROJECTED EMRA MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 102
TRENDS IN THE EMRA NEUROVASCULAR CATHETER MARKET 102
SPECIALTY CATHETER MARKET 103
TABLE 36 PROJECTED EMRA MARKET FOR SPECIALTY CATHETERS, THROUGH 2016 ($ MILLIONS) 103
TRENDS IN THE EMRA SPECIALTY CATHETER MARKET 103
CHAPTER NINE: THE ASIAN CATHETER MARKET 104
REGIONAL ECONOMIC CONSIDERATIONS 104
TABLE 37 PROJECTED ASIAN CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 104
GDP AND GROWTH RATES 105
TABLE 38 GDP OF SELECTED ASIAN COUNTRIES, GDP GROWTH RATE, PERCENT OF GDP DEVOTED TO HEALTHCARE 105
REGULATIONS AND HEALTHCARE COVERAGE IN THE
AUSTRALIAN MARKET 105
Health Insurance in Australia 106
REGULATIONS AND HEALTHCARE COVERAGE IN THE
JAPANESE MARKET 106
REGULATIONS AND HEALTHCARE COVERAGE IN THE
INDIAN MARKET 106
Medical Insurance in India 107
Growth of the Indian Healthcare Industry 107
REGULATIONS AND HEALTHCARE COVERAGE IN THE CHINESE MARKET 107
Medical Device Regulations 107
Chinese Healthcare Institutions 108
Rural and Urban Healthcare Services 108
ASIAN CATHETER MARKET BY TYPE OF PRODUCT 109
TABLE 39 PROJECTED ASIAN CATHETER MARKET BY PRODUCT TYPE, THROUGH 2016 ($ MILLIONS) 109
CARDIOVASCULAR MARKET 109
TABLE 40 PROJECTED ASIAN CARDIOVASCULAR CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 110
Trends in the Asian Cardiovascular Catheter Market 110
UROLOGY CATHETER MARKET 110
TABLE 41 PROJECTED ASIAN UROLOGY CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 111
Trends in the Asian Urological Catheter Market 111
INTRAVENOUS CATHETER MARKET 111
TABLE 42 PROJECTED ASIAN INTRAVENOUS CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 111
Trends in the Asian IV Catheter Market 112
NEUROVASCULAR CATHETER MARKET 112
TABLE 43 PROJECTED ASIAN NEUROVASCULAR CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 112
Trends in the Asian Neurological Catheter Market 112
SPECIALTY CATHETER MARKET 113
TABLE 44 PROJECTED ASIAN SPECIALTY CATHETER MARKET, THROUGH 2016 ($ MILLIONS) 113
Trends in the Asian Specialty Catheter Market 113
CHAPTER TEN: PATENT ANALYSIS 114
GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 114
TABLE 45 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 114
CATHETER PATENT ACTIVITY BY ASSIGNEE 115
TABLE 46 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY 2008-SEPTEMBER 2011 (NUMBER OF
PATENTS) 115
CARDIOVASCULAR CATHETER PATENTS 116
TABLE 47 CARDIOVASCULAR CATHETER PATENTS BY TYPE, JANUARY 2008-SEPTEMBER 2011 116
TABLE 48 CARDIAC CATHETER PATENTS, NOVEMBER 2011- JANUARY 2008 117
TABLE 49 BALLOON CATHETER PATENTS, APRIL 2011-JANUARY 2008 120
TABLE 50 CARDIAC GUIDE CATHETER PATENTS, NOVEMBER 2011-JANUARY 2008 121
TABLE 51 CARDIAC GUIDEWIRE PATENTS, 2010 122
UROLOGY CATHETER PATENTS 122
IV CATHETER PATENTS 122
TABLE 52 IV CATHETER PATENTS BY TYPE, JANUARY 2008- SEPTEMBER 2011 122
TABLE 53 IV CATHETER PATENTS, JUNE 2009-SEPTEMBER 2008 123
SPECIALTY CATHETER PATENTS 123
TABLE 54 SPECIALTY CATHETER PATENTS BY TYPE, JANUARY 2008-SEPTEMBER 2011 124
TABLE 55 SPECIALTY CATHETER PATENTS, OCTOBER 2011 124
CATHETER COATINGS 126
TABLE 56 CATHETER COATING PATENTS, JANUARY 2008-SEPTEMBER 2011 126
TABLE 57 CATHETER COATING PATENTS, JULY 2011-JUNE 2009 126
CHAPTER ELEVEN: COMPANY DIRECTORY 128
ABBOTT LABORATORIES 128
BUSINESS OVERVIEW 128
FINANCIAL 128
PRODUCTS 129
TABLE 58 ABBOTT LABORATORIES CATHETER PRODUCTS 129
ANGIODYNAMICS 129
BUSINESS OVERVIEW 129
FINANCIALS 130
PRODUCTS 130
TABLE 59 ANGIODYNAMICS CATHETER PRODUCTS 130
ASTRA TECH INC, UROLOGY DIVISION 130
BUSINESS OVERVIEW 131
FINANCIALS 131
PRODUCTS 131
TABLE 60 ASTRA TECH CATHETER PRODUCTS 131
B BRAUN MELSUNGEN AG 132
BUSINESS OVERVIEW 132
FINANCIALS 132
PRODUCTS 132
TABLE 61 B BRAUN CATHETER PRODUCTS 132
BECTON DICKINSON & CO 133
BUSINESS OVERVIEW 133
FINANCIALS 134
PRODUCTS 134
TABLE 62 BD CATHETER PRODUCTS 134
BOSTON SCIENTIFIC 134
BUSINESS OVERVIEW 135
FINANCIALS 135
PRODUCTS 135
TABLE 63 BOSTON SCIENTIFIC CATHETER PRODUCTS 135
CARDINAL HEALTH 136
BUSINESS OVERVIEW 136
FINANCIALS 137
PRODUCTS 137
TABLE 64 CARDINAL HEALTH CATHETER PRODUCTS 137
CAREFUSION CORP 137
BUSINESS OVERVIEW 138
FINANCIALS 138
PRODUCTS 138
TABLE 65 CAREFUSION CATHETER PRODUCTS 138
CODMAN & SHURTLEFF (DEPUY) 138
BUSINESS OVERVIEW 138
FINANCIALS 139
PRODUCTS 139
TABLE 66 CODMAN & SHURTLEFF CATHETER PRODUCTS 139
COLOPLAST GROUP 139
FINANCIALS 140
PRODUCTS 140
TABLE 67 COLOPLAST CATHETER PRODUCTS 140
COOK MEDICAL 140
BUSINESS OVERVIEW 140
FINANCIALS 141
PRODUCTS 141
TABLE 68 COOK MEDICAL CATHETER PRODUCTS 141
COVIDIEN 142
BUSINESS OVERVIEW 142
FINANCIALS 142
PRODUCTS 143
TABLE 69 COVIDIEN CATHETER PRODUCTS 143
C R BARD 144
BUSINESS OVERVIEW 144
FINANCIALS 144
PRODUCTS 144
TABLE 70 C R BARD CATHETER PRODUCTS 144
EDWARDS LIFESCIENCES 146
BUSINESS OVERVIEW 146
FINANCIALS 146
PRODUCTS 147
TABLE 71 EDWARDS LIFESCIENCES CATHETER PRODUCTS 147
EV3 ENDOVASCULAR INC (COVIDIEN) 147
BUSINESS OVERVIEW 147
FINANCIALS 147
PRODUCTS 148
TABLE 72 EV3 CATHETER PRODUCTS 148
GOODMAN CO LTD 148
BUSINESS OVERVIEW 148
FINANCIALS 149
PRODUCTS 149
TABLE 73 GOODMAN CATHETER PRODUCTS 149
HOLLISTER 149
BUSINESS OVERVIEW 149
FINANCIALS 149
PRODUCTS 150
TABLE 74 HOLLISTER CATHETER PRODUCTS 150
HOSPIRA INC 150
BUSINESS OVERVIEW 150
FINANCIALS 150
PRODUCTS 150
TABLE 75 HOSPIRA CATHETER PRODUCTS 150
ICU MEDICAL 151
BUSINESS OVERVIEW 151
FINANCIALS 151
PRODUCTS 151
TABLE 76 ICU MEDICAL CATHETER PRODUCTS 151
INTEGRA LIFE SCIENCES 152
BUSINESS OVERVIEW 152
FINANCIALS 152
PRODUCTS 152
TABLE 77 INTEGRA LIFESCIENCES CATHETER PRODUCTS 152
JOHNSON & JOHNSON 152
BUSINESS OVERVIEW 153
FINANCIALS 153
PRODUCTS 153
TABLE 78 JOHNSON & JOHNSON CATHETER PRODUCTS 153
KIMBERLY CLARK HEALTHCARE 154
BUSINESS OVERVIEW 154
FINANCIALS 155
PRODUCTS 155
TABLE 79 KIMBERLY CLARK HEALTHCARE CATHETER PRODUCTS 155
MEDCOMP 155
BUSINESS OVERVIEW 155
FINANCIALS 155
PRODUCTS 156
TABLE 80 MEDCOMP CATHETER PRODUCTS 156
MEDLINE INDUSTRIES 156
BUSINESS OVERVIEW 156
FINANCIALS 157
PRODUCTS 157
TABLE 81 MEDLINE CATHETER PRODUCTS 157
MEDRAD (BAYER AG) 157
BUSINESS OVERVIEW 157
FINANCIALS 158
PRODUCTS 158
TABLE 82 MEDRAD CATHETER PRODUCTS 158
MEDTRONIC 158
BUSINESS OVERVIEW 158
FINANCIALS 159
PRODUCTS 159
TABLE 83 MEDTRONIC CATHETER PRODUCTS 159
MERIT MEDICAL SYSTEMS 160
BUSINESS OVERVIEW 160
FINANCIALS 160
PRODUCTS 160
TABLE 84 MERIT MEDICAL CATHETER PRODUCTS 160
NAVILYST MEDICAL 161
BUSINESS OVERVIEW 161
FINANCIALS 161
PRODUCTS 162
TABLE 85 NAVILYST MEDICAL CATHETER PRODUCTS 162
PULSION MEDICAL AG 162
BUSINESS OVERVIEW 162
FINANCIALS 162
PRODUCTS 163
TABLE 86 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS 163
ROCHESTER MEDICAL 163
BUSINESS OVERVIEW 163
FINANCIALS 163
PRODUCTS 164
TABLE 87 ROCHESTER MEDICAL CATHETER PRODUCTS 164
SMITHS MEDICAL 164
BUSINESS OVERVIEW 164
FINANCIALS 165
PRODUCTS 165
TABLE 88 SMITHS MEDICAL CATHETER PRODUCTS 165
ST JUDE MEDICAL 166
BUSINESS OVERVIEW 166
FINANCIALS 166
PRODUCTS 166
TABLE 89 ST JUDE MEDICAL CATHETER PRODUCTS 166
STRYKER 167
BUSINESS OVERVIEW 167
FINANCIALS 168
PRODUCTS 168
TABLE 90 STRYKER CATHETER PRODUCTS 168
TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 168
BUSINESS OVERVIEW 168
FINANCIALS 169
PRODUCTS 169
TABLE 91 TELEFLEX CATHETER PRODUCTS 169
TERUMO MEDICAL CORP 170
BUSINESS OVERVIEW 170
FINANCIALS 170
PRODUCTS 170
TABLE 92 TERUMO CATHETER PRODUCTS 170
VASCULAR SOLUTIONS 171
BUSINESS OVERVIEW 171
FINANCIALS 172
PRODUCTS 172
TABLE 93 VASCULAR SOLUTIONS CATHETER PRODUCTS 172
VOLCANO CORPORATION 172
BUSINESS OVERVIEW 172
FINANCIALS 173
PRODUCTS 173
TABLE 94 VOLCANO CORPORATION CATHETER PRODUCTS 173
APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 174
TABLE 95 CATHETER PRODUCTS BY APPLICATION, TYPE, BRAND NAME, AND MANUFACTURER 174
